Detailed Narrative
Q2 FY26 Financial Performance Overview
Sharda Cropchem reported a robust Q2 FY26, with total revenues growing by 20% year-on-year to INR929 crores. This performance was underpinned by a significant overall volume growth of 35%. The agrochemical segment, which is the core business, saw a 27% year-on-year revenue increase to INR803 crores, while its volumes grew by 36%. In contrast, the non-agrochemical segment experienced an 11% year-on-year decline in revenue, reaching INR126 crores.
Gross Margin Expansion and Profitability
The company demonstrated strong profitability improvements, with gross margins expanding by 690 basis points to 34.5% in Q2 FY26, compared to 27.6% in Q2 FY25. This expansion was attributed to stabilizing input costs. Consequently, EBITDA for the quarter grew by an impressive 71% year-on-year, reaching INR139 crores, with the EBITDA margin standing at 15%. PAT also saw a substantial increase of 75% year-on-year, amounting to INR74 crores.
Working Capital and Liquidity Management
Sharda Cropchem continued its focus on efficient working capital management, with working capital days improving by 34 days to 84 days as of September 30, 2025, compared to March 2025. The company maintains a debt-free status, reinforcing its strong financial position. Furthermore, it held significant cash and liquid investments totaling INR794 crores as of September 30, 2025, providing ample liquidity for future operations and strategic initiatives.
Product Registrations and Capex Plans
The company's strategy of securing product registrations globally continues to be a key differentiator. As of September 30, 2025, Sharda Cropchem had 2,994 product registrations, with an additional 1,068 applications in various stages of approval worldwide. To further strengthen its market position and pipeline, the company plans a capital expenditure of INR450 crores to INR500 crores for FY26, with INR250 crores already spent in H1 FY26.
Regional Performance and Product Mix Dynamics
Geographically, Europe contributed 43% to the gross margin, NAFTA 23%, LATAM 20%, and the rest of the world 40%. Management clarified that revenue growth is influenced by volume growth (34.8%), FX impact🌐 (1.9%), and product mix (17%). The product mix refers to the varying price points of different products, where higher demand for higher-priced products can lead to increased revenue even with lower volumes, and vice versa, impacting overall margins.
Forex Impact and US Tariffs Clarification
Management addressed concerns regarding forex losses, stating that the minor loss reported in Q2 FY26 was notional and primarily due to cross-currency exchange rates and realignment of capex payables. They emphasized that it was not a real operational loss. Regarding US tariffs, the company asserted that there would be no substantial impact on its business, as the specialized nature of its registered products allows for tariffs to be passed on to customers, who are willing to pay due to limited alternative suppliers.